A new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axis

Laura J Niedernhofer1, George A Garinis, Anja Raams

  • 1Center for Biomedical Genetics Medical Genetic Center Department of Cell Biology and Genetics, Erasmus Medical Center, PO Box 1738, 3000 DR Rotterdam, The Netherlands.

Nature
|December 22, 2006
PubMed

Insights

Unrepaired DNA damage accelerates aging by triggering a conserved metabolic response that prioritizes survival over growth. This finding links DNA repair to lifespan and aging processes.

Area of Science:

  • Genetics
  • Molecular Biology
  • Aging Research

Background:

  • XPF-ERCC1 endonuclease is crucial for repairing DNA lesions and interstrand crosslinks.
  • XPF gene mutations can cause xeroderma pigmentosum, a cancer predisposition syndrome.
  • Severe XPF mutations lead to progeroid symptoms, but the link between DNA damage and aging is unclear.

Purpose of the Study:

  • To investigate the relationship between unrepaired DNA damage and accelerated aging.
  • To explore the metabolic and molecular changes associated with DNA damage-induced progeroid symptoms.
  • To understand the relevance of DNA damage to natural aging processes.

Main Methods:

  • Comparative transcriptome analysis of old mice and a mouse model with a severe XPF mutation.
  • Examination of gene expression patterns related to cell death, antioxidant defenses, and growth signaling.
  • Correlation analysis between liver gene expression and aging phenotypes.

Main Results:

  • A significant correlation was found between the liver transcriptome of old mice and the progeroid mouse model.
  • XPF-ERCC1-deficient mice exhibited increased cell death, enhanced antioxidant defenses, and reduced IGF1 signaling.
  • Similar molecular changes were observed in wild-type mice subjected to genotoxic stress, caloric restriction, or natural aging.

Conclusions:

  • Unrepaired cytotoxic DNA damage induces a conserved metabolic response, mediated by the IGF1/insulin pathway.
  • This response shifts resources from growth to somatic preservation, potentially extending lifespan.
  • DNA damage causally contributes to aging, with stochastic damage and genetics determining decline rates.

Related Concept Videos

Exon Recombination02:32

Exon Recombination

The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes. 
Exon shuffling follows “splice frame rules.” Each exon...
3.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
6.9K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
81
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
2.0K